Clinical implications of the deregulated TP73 isoforms expression in cancer. (Q48136784)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:29230693 AND SRC:MED&resulttype=core&format=json

7 April 2020

review article

1 reference

title

Clinical implications of the deregulated TP73 isoforms expression in cancer (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:29230693 AND SRC:MED&resulttype=core&format=json

7 April 2020

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:29230693 AND SRC:MED&resulttype=core&format=json

7 April 2020

author name string

N Rodríguez

series ordinal

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:29230693 AND SRC:MED&resulttype=core&format=json

7 April 2020

A Peláez

series ordinal

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:29230693 AND SRC:MED&resulttype=core&format=json

7 April 2020

R Barderas

series ordinal

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:29230693 AND SRC:MED&resulttype=core&format=json

7 April 2020

publication date

11 December 2017

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:29230693 AND SRC:MED&resulttype=core&format=json

Clinical and Translational Oncology

7 April 2020

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:29230693 AND SRC:MED&resulttype=core&format=json

7 April 2020

volume

20

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:29230693 AND SRC:MED&resulttype=core&format=json

7 April 2020

issue

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:29230693 AND SRC:MED&resulttype=core&format=json

7 April 2020

page(s)

827-836

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:29230693 AND SRC:MED&resulttype=core&format=json

TAp73 opposes tumor angiogenesis by promoting hypoxia-inducible factor 1α degradation

7 April 2020

cites work

1 reference

https://api.crossref.org/works/10.1007/S12094-017-1802-3

Overexpressed TP73 induces apoptosis in medulloblastoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S12094-017-1802-3

Relationship between expression of P27, Fragile Histidine Triad (FHT), phosphatase and tensin homolog deleted on chromosome ten (PTEN), P73, and prognosis in esophageal squamous cell carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S12094-017-1802-3

Differential expression of p53 gene family members p63 and p73 in head and neck squamous tumorigenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S12094-017-1802-3

Transdominant DeltaTAp73 isoforms are frequently up-regulated in ovarian cancer. Evidence for their role as epigenetic p53 inhibitors in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S12094-017-1802-3

Clinical relevance of dominant-negative p73 isoforms for responsiveness to chemotherapy and survival in ovarian cancer: evidence for a crucial p53-p73 cross-talk in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S12094-017-1802-3

A nano-enabled cancer-specific ITCH RNAi chemotherapy booster for pancreatic cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S12094-017-1802-3

DeltaTAp73 upregulation correlates with poor prognosis in human tumors: putative in vivo network involving p73 isoforms, p53, and E2F-1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S12094-017-1802-3

Hypoxia-induced DNp73 stabilization regulates Vegf-A expression and tumor angiogenesis similar to TAp73.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S12094-017-1802-3

P73 expression in basal layers of head and neck squamous epithelium: a role in differentiation and carcinogenesis in concert with p53 and p63?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S12094-017-1802-3

Involvement of N-terminally truncated variants of p73, deltaTAp73, in head and neck squamous cell cancer: a comparison with p53 mutations

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S12094-017-1802-3

p63 and p73 coordinate p53 function to determine the balance between survival, cell death, and senescence in adult neural precursor cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S12094-017-1802-3

p73 is required for endothelial cell differentiation, migration and the formation of vascular networks regulating VEGF and TGFβ signaling

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S12094-017-1802-3

Transactivation-deficient p73alpha (p73Deltaexon2) inhibits apoptosis and competes with p53.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S12094-017-1802-3

IL-17, IL-23, and p73 expression in cutaneous melanoma: a pilot study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S12094-017-1802-3

p73 is required for ependymal cell maturation and neurogenic SVZ cytoarchitecture.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S12094-017-1802-3

Human delta Np73 regulates a dominant negative feedback loop for TAp73 and p53.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S12094-017-1802-3

Aberrant expression of DeltaNp73 in benign and malignant tumours of the prostate: correlation with Gleason score

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S12094-017-1802-3

TAp73 and ΔNp73 relative expression in Egyptian patients with lymphoid neoplasms

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S12094-017-1802-3

p63 and p73 expression in extrahepatic bile duct carcinoma and their clinical significance

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S12094-017-1802-3

TBCRC009: A Multicenter Phase II Clinical Trial of Platinum Monotherapy With Biomarker Assessment in Metastatic Triple-Negative Breast Cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S12094-017-1802-3

21 January 2018

Global cancer statistics

1 reference

https://api.crossref.org/works/10.1007/S12094-017-1802-3

p73 is a simian [correction of human] p53-related protein that can induce apoptosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S12094-017-1802-3

Monoallelically Expressed Gene Related to p53 at 1p36, a Region Frequently Deleted in Neuroblastoma and Other Human Cancers

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S12094-017-1802-3

p73: a multifunctional protein in neurobiology

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S12094-017-1802-3

p73 promotes glioblastoma cell invasion by directly activating POSTN (periostin) expression

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S12094-017-1802-3

The p63/p73 network mediates chemosensitivity to cisplatin in a biologically defined subset of primary breast cancers

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S12094-017-1802-3

p63 and p73 transcriptionally regulate genes involved in DNA repair

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S12094-017-1802-3

High ΔNp73/TAp73 ratio is associated with poor prognosis in acute promyelocytic leukemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S12094-017-1802-3

p73: Friend or foe in tumorigenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S12094-017-1802-3

TAp73 knockout mice show morphological and functional nervous system defects associated with loss of p75 neurotrophin receptor

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S12094-017-1802-3

p73 is over-expressed in vulval cancer principally as the Delta 2 isoform

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S12094-017-1802-3

Recent advances in p53 research: an interdisciplinary perspective.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S12094-017-1802-3

An anti-apoptotic role for the p53 family member, p73, during developmental neuron death

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S12094-017-1802-3

Stage-independent expression and genetic analysis of tp73 in neuroblastoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S12094-017-1802-3

Wild-type p53 and p73 negatively regulate expression of proliferation related genes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S12094-017-1802-3

ΔNp73β is oncogenic in hepatocellular carcinoma by blocking apoptosis signaling via death receptors and mitochondria

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S12094-017-1802-3

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S12094-017-1802-3

Prognostic impact of ΔTAp73 isoform levels and their target genes in colon cancer patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S12094-017-1802-3

Tumor-derived exosomes are enriched in ΔNp73, which promotes oncogenic potential in acceptor cells and correlates with patient survival

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S12094-017-1802-3

Evaluation of promoter hypomethylation and expression of p73 as a diagnostic and prognostic biomarker in Wilms' tumour

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S12094-017-1802-3

DNp73 exerts function in metastasis initiation by disconnecting the inhibitory role of EPLIN on IGF1R-AKT/STAT3 signaling.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S12094-017-1802-3

Transactivation-deficient Delta TA-p73 inhibits p53 by direct competition for DNA binding: implications for tumorigenesis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S12094-017-1802-3

TAp73 loss favors Smad-independent TGF-β signaling that drives EMT in pancreatic ductal adenocarcinoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S12094-017-1802-3

TAp73 knockout shows genomic instability with infertility and tumor suppressor functions

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S12094-017-1802-3

The prognostic value of p73 overexpression in colorectal carcinoma: a clinicopathologic, immunohistochemical, and statistical study of 204 patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S12094-017-1802-3

Alterations of DeltaTA-p 73 splice transcripts during melanoma development and progression

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S12094-017-1802-3

Expression of deltaNp73 predicts poor prognosis in lung cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S12094-017-1802-3

DeltaNp73alpha regulates MDR1 expression by inhibiting p53 function

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S12094-017-1802-3

Characterization of ΔNp73 expression and regulation in gastric and esophageal tumors.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S12094-017-1802-3

Prognostic value of increase in transcript levels of Tp73 DeltaEx2-3 isoforms in low-grade glioma patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S12094-017-1802-3

Expression of p53 and its homologues in primary and recurrent squamous cell carcinomas of the head and neck

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S12094-017-1802-3

Isoform-specific p73 knockout mice reveal a novel role for delta Np73 in the DNA damage response pathway

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S12094-017-1802-3

DeltaNp73, a dominant-negative inhibitor of wild-type p53 and TAp73, is up-regulated in human tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S12094-017-1802-3

p73 expression in medulloblastoma: TAp73/DeltaNp73 transcript detection and possible association of p73alpha/DeltaNp73 immunoreactivity with survival.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S12094-017-1802-3

Expression of Ki-67, Bax and p73 in patients with hilar cholangiocarcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S12094-017-1802-3

Mutation, allelotyping, and transcription analyses of the p73 gene in prostatic carcinoma

21 January 2018

1 reference

12 December 2020

Mutation and expression analysis of the p73 gene in prostate cancer

1 reference

12 December 2020

Expression of p73 and p63 proteins in pancreatic adenocarcinoma: p73 overexpression is inversely correlated with biological aggressiveness

1 reference

12 December 2020

p73 overexpression is a prognostic factor in patients with colorectal adenocarcinoma

1 reference

12 December 2020

Possible oncogenic potential of DeltaNp73: a newly identified isoform of human p73

1 reference

12 December 2020

Expression of DeltaNp73 is a molecular marker for adverse outcome in neuroblastoma patients

1 reference

12 December 2020

Differential expression of p53, p63 and p73 proteins in human buccal squamous-cell carcinomas

1 reference

12 December 2020

p73 Expression in human normal and tumor tissues: loss of p73alpha expression is associated with tumor progression in bladder cancer.

1 reference

12 December 2020

Low expression of p63 and p73 in osteosarcoma

1 reference

12 December 2020

P73 status in B-cell chronic lymphocytic leukaemia

1 reference

12 December 2020

Analysis of p73 expression pattern in acute myeloid leukemias: lack of DeltaN-p73 expression is a frequent feature of acute promyelocytic leukemia

1 reference

12 December 2020

Expression of TAp73 and DeltaNp73 isoform transcripts in thyroid tumours

1 reference

12 December 2020

Delta Np73 expression in thyroid neoplasms originating from follicular cells

1 reference

12 December 2020

Differential expression of p73 isoforms in relation to drug resistance in childhood T-lineage acute lymphoblastic leukaemia

1 reference

12 December 2020

Expression of deltaNp73 and TAp73alpha independently associated with radiosensitivities and prognoses in cervical squamous cell carcinoma

1 reference

12 December 2020

Patterns of p73 N-terminal isoform expression and p53 status have prognostic value in gynecological cancers.

1 reference

12 December 2020

Increased expression of p73Deltaex2 transcript in uveal melanoma with loss of chromosome 1p

1 reference

12 December 2020

p63 and p73 isoform expression in non-small cell lung cancer and corresponding morphological normal lung tissue

1 reference

12 December 2020

Differential expression of p53 family proteins in colorectal adenomas and carcinomas: Prognostic and predictive values

1 reference

12 December 2020

Expression and clinical implications of P53, P63, and P73 protein in malignant tumor of the parotid gland.

1 reference

12 December 2020

Expression and prognostic significance of TAp73 and ΔNp73 in FIGO stage I-II cervical squamous cell carcinoma

1 reference

12 December 2020

10.1007/S12094-017-1802-3

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:29230693 AND SRC:MED&resulttype=core&format=json

7 April 2020

1 reference